Barrier-reinforcing hyaluronic acid-bilirubin nanodelivery of methylprednisolone for synergistic modulation of the intestinal barrier, immune system, and gut microbiome in colitis.
Inflammatory bowel disease (IBD) is characterized by a self-reinforcing cycle of intestinal barrier dysfunction, gut microbiome dysbiosis, and aberrant mucosal immune responses. Methylprednisolone (MPS) is a potent immunosuppressant used for IBD and may beneficially modulate the gut microbiome, but its systemic adverse...